Crucell, Bavarian Land $28.5m U.S. Ebola Vaccine Award

15 Sep 2015

• By Donna Young

Biomedical Advanced Research and Development Authority (BARDA) has awarded Johnson & Johnson subsidiary Crucell Holland and Bavarian Nordic $28.5m over four years to advance their experimental prime-boost Ebola vaccine.

Crucell, Bavarian Land $28.5m U.S. Ebola Vaccine Award

More from Immunological

More from Therapy Areas